Advertisement
Screener

Rocket Pharmaceuticals, Inc. (RCKT) Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay

2.8 / 5 stars · 68/120 Roast Me

Rocket Pharmaceuticals, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay

Rocket Pharmaceuticals, Inc. (RCKT) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 4.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan

us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-08-10

  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2026-03-31 was 4.00%, a 0.00% change year-over-year.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2025-03-31 was 4.00%, a 0.00% change year-over-year.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2024-03-31 was 4.00%, a 0.00% change year-over-year.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2023-03-31 was 4.00%, a 0.00% change year-over-year.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 4.00%, a 0.00% change from fiscal 2024.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 4.00%, a 0.00% change from fiscal 2023.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2023 was 4.00%, a 0.00% change from fiscal 2022.
  • Rocket Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2022 was 4.00%, a 0.00% change from fiscal 2021.
Period endDefined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 3 monthDefined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 6 monthDefined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 9 monthDefined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month
2026-06-304.00%
10-Q · filed 2026-08-10
2026-03-314.00%
10-Q · filed 2026-05-07
2025-12-314.00%
10-K · filed 2026-02-26
2025-09-304.00%
10-Q · filed 2025-11-06
2025-06-304.00%
10-Q · filed 2025-08-07
2025-03-314.00%
10-Q · filed 2025-05-08
2024-12-314.00%
10-K · filed 2025-02-27
2024-09-304.00%
10-Q · filed 2024-11-07
2024-06-304.00%
10-Q · filed 2024-08-06
2024-03-314.00%
10-Q · filed 2024-05-07
2023-12-314.00%
10-K · filed 2024-02-27
2023-09-304.00%
10-Q · filed 2023-11-07
2023-06-304.00%
10-Q · filed 2023-08-09
2023-03-314.00%
10-Q · filed 2023-05-05
2022-12-314.00%
10-K · filed 2023-02-28
2022-09-304.00%
10-Q · filed 2022-11-04
2022-06-304.00%
10-Q · filed 2022-08-09
2022-03-314.00%
10-Q · filed 2022-05-06
2021-12-314.00%
10-K · filed 2022-02-28
2021-09-304.00%
10-Q · filed 2021-11-05
2021-06-304.00%
10-Q · filed 2021-08-09
2021-03-314.00%
10-Q · filed 2021-05-10
2020-12-314.00%
10-K · filed 2021-03-01
2020-09-304.00%
10-Q · filed 2020-11-06
2020-06-304.00%
10-Q · filed 2020-08-05
2020-03-314.00%
10-Q · filed 2020-05-08
2019-12-314.00%
10-K · filed 2020-03-06
2019-09-304.00%
10-Q · filed 2019-11-08
2019-06-304.00%
10-Q · filed 2019-08-08
2019-03-314.00%
10-Q · filed 2019-05-09
2018-12-314.00%
10-K · filed 2019-03-08
2018-09-304.00%
10-Q · filed 2018-11-09
2018-06-304.00%
10-Q · filed 2018-08-14
2018-03-314.00%
10-Q · filed 2018-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01